Oscar Health Inc Class A (OSCR) valuation
Oscar Health P/E ratio history
Oscar Health trades at 20.9 times its earnings over the last twelve months and 14.6 times the earnings analysts expect over the next twelve.
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
Oscar Health valuation against its peers
| Company | Market value | P/E | Forward P/E |
|---|---|---|---|
| Oscar HealthOSCR | $9.16B | 20.9 | 14.6 |
| Jackson FinancialJXN | $9.41B | 164.6 | 4.6 |
| Old National BancorpONB | $9.60B | 10.2 | 9.1 |
| Umb FinancialUMBF | $10.2B | 10.1 | 9.6 |
| FirstcashFCFS | $7.86B | 19.6 | 14.7 |
| Valley NationalVLY | $7.83B | 12.0 | 9.6 |
| Freedom HoldingFRHC | $11.5B | 77.3 | — |
| Jack Henry & AssociatesJKHY | $11.5B | 23.1 | 21.8 |
| FactSetFDS | $11.7B | 22.6 | 16.8 |
| Peer median | 21.1 | 9.6 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: OSCR returns
No forecast, no recommendation. This page describes Oscar Health Inc Class A from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.